These results indicated that high CD44/CD24 ratio was highly associated with the proliferative capacity and the tumorigenicity of breast cancer, suggesting that CD44/CD24 is a powerful CSC marker for breast cancer. The gene discussed is CD24; the disease is breast carcinoma.